Bone Biologics Corp Common Stock

BBLGNASDAQUSD
1.25 USD
0.02 (1.59%)🔴AT CLOSE (AS OF 07:07 PM EDT)
🔴Market: CLOSED

BBLG is currently priced at $1.25. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, BBLG appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jul 15, 2026.

Open?$1.26
High?$1.26
Low?$1.20
Prev. Close?$1.26
Volume?32.1K
Avg. Volume?106.6K
VWAP?$1.25
Rel. Volume?0.30x
Bid / Ask
Bid?$1.20 × 100
Ask?$1.28 × 3.7K
Spread?$0.08
Midpoint?$1.24
Valuation & Ratios
Market Cap?2.2M
Shares Out?1.8M
Float?1.7M
Float %?92.2%
P/E Ratio?N/A
P/B Ratio?0.48
EPS?-$1.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Employees
2
Market Cap
2.3M
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2015-11-27
Address
2 BURLINGTON WOODS DRIVE,
BURLINGTON, MA 01803
Phone: (781) 552-4452
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?-21.52Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.07%Low
Short Interest?67.3K
Days to Cover?1.0
Free Float1.7M
Avg Daily Volume201.8K
Settlement Date2026-06-30
Financial Health
Current Ratio?15.42Strong
Quick Ratio?15.42Strong
Cash Ratio?14.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.48CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
0.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-61.2%WEAK
ROA?
S&P
3
-57.4%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-2303918
Fundamentals ratios updated end of day